McGuff Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsMcGuff Pharmaceuticals

McGuff Pharmaceuticals

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Ascor	Ascorbic acid	2017-10-02	2024-2033	Common cold , Constipation , Methemoglobinemia , Penetrating wounds , Tyrosinemias , Scurvy , Hypercholesterolemia , Hypophosphatemia , Hypertriglyceridemia , Peripheral vascular diseases , Dermatitis , Alcoholic neuropathy , Seizures , Vitamin a deficiency , Hypoparathyroidism , Inborn errors metabolism , Photosensitivity disorders , Thiamine deficiency , Folic acid deficiency , Rickets , Vitamin b 6 deficiency , Megaloblastic anemia , Vitamin b deficiency , Xerophthalmia , Wernicke encephalopathy , Beriberi , Night blindness , Riboflavin deficiency , Pellagra , Chronic kidney failure , Cardiovascular diseases , Psoriasis , Lung neoplasms , Crohn disease , Skin neoplasms , Familial hypophosphatemic rickets , Osteoporosis

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

keratoconjunctivitis sicca

,

dry eye syndromes

,

healthy volunteers/patients

,

retinal diseases

,

diabetic retinopathy

,

Aglatimagene besadenovec

renal cell carcinoma

,

colonic neoplasms

,

,

urethral neoplasms

,

transitional cell carcinoma

,

neuroendocrine carcinoma

,

,

,

non-small-cell lung carcinoma

,

urinary bladder neoplasms

,

urologic neoplasms

,

small cell lung carcinoma

,

breast neoplasms

,

,

,

neuroendocrine tumors

,

ovarian neoplasms

,

uterine cervical neoplasms

,

small cell carcinoma

,

,

triple negative breast neoplasms

,

colorectal neoplasms

,

hepatocellular carcinoma

,

liver neoplasms

,

squamous cell carcinoma

,

,

disease progression

,

squamous cell carcinoma of head and neck

,

,

pancreatic neoplasms

,

endometrial neoplasms

,

stomach neoplasms

,

head and neck neoplasms

,

esophageal neoplasms

,

ovarian epithelial carcinoma

,

neoplasm metastasis

,

hypersensitivity

,

prostatic neoplasms

,

castration-resistant prostatic neoplasms

,

prostatic hyperplasia

,

,

disease susceptibility

breast neoplasms

,

non-small-cell lung carcinoma

,

,

healthy volunteers/patients

,

,

stomach neoplasms

,

esophageal neoplasms

,

rectal neoplasms

,

head and neck neoplasms

,

squamous cell carcinoma of head and neck

,

squamous cell carcinoma

,

squamous cell neoplasms

,

,

sigmoid neoplasms

,

mucinous adenocarcinoma

,

colonic neoplasms

,

cystadenocarcinoma

,

,

,

ovarian neoplasms

,

ovarian epithelial carcinoma

,

colorectal neoplasms

,

,

rheumatoid arthritis

,

,

pulmonary embolism

,

,

atrial fibrillation

,

,

venous thrombosis

,

,

liver neoplasms

,

pancreatic neoplasms

,

thromboembolism

,

prostatic neoplasms

,

gastrointestinal neoplasms

,

,

neuroendocrine tumors

,

carcinoid tumor

,

paraneoplastic syndromes

,

islet cell adenoma

,

malignant carcinoid syndrome

,

chronic kidney disease-mineral and bone disorder

,

hypercholesterolemia

,

hyperlipoproteinemia type ii

,

hepatocellular carcinoma

,

neurotoxicity syndromes

,

,

neoplasm metastasis

,

hyperparathyroidism

,

secondary hyperparathyroidism

,

chronic renal insufficiency

,

kidney diseases

,

renal insufficiency

,

,

,

spinal fractures

,

kidney transplantation

,

venous thromboembolism

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use